COVID‐19‐related anxiety predicts somatic symptoms in the UK population

This study aimed to estimate the association between anxiety associated with COVID‐19 and somatic symptoms, using data from a large, representative sample (N = 2,025) of the UK adult population. Results showed that moderate to high levels of anxiety associated with COVID‐19 were significantly associated with general somatic symptoms and in particular with gastrointestinal and fatigue symptoms. This pattern of associations remained significant after controlling for generalized anxiety disorder (GAD), pre‐existing health problems, age, gender, and income. This is the first evidence that anxiety associated with COVID‐19 makes a unique contribution to somatization, above and beyond the effect of GAD.

[1]  P. Hyland,et al.  Anxiety, depression, traumatic stress and COVID-19-related anxiety in the UK general population during the COVID-19 pandemic , 2020, BJPsych Open.

[2]  P. Hyland,et al.  Monitoring the psychological impact of the COVID-19 pandemic in the general population: an overview of the context, design and conduct of the COVID-19 Psychological Research Consortium (C19PRC) Study , 2020 .

[3]  Yeen Huang,et al.  Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey , 2020, Psychiatry Research.

[4]  Mingyi Zhao,et al.  Comparison of the Indicators of Psychological Stress in the Population of Hubei Province and Non-Endemic Provinces in China During Two Weeks During the Coronavirus Disease 2019 (COVID-19) Outbreak in February 2020 , 2020, Medical science monitor : international medical journal of experimental and clinical research.

[5]  A. Cano-Vindel,et al.  Latent structure and factor invariance of somatic symptoms in the patient health questionnaire (PHQ-15). , 2020, Journal of affective disorders.

[6]  K. Petrowski,et al.  Frequency of somatic symptoms in the general population: Normative values for the Patient Health Questionnaire-15 (PHQ-15). , 2017, Journal of psychosomatic research.

[7]  B. Löwe,et al.  A brief measure for assessing generalized anxiety disorder: the GAD-7. , 2006, Archives of internal medicine.

[8]  H. Hull,et al.  SARS Control and Psychological Effects of Quarantine, Toronto, Canada , 2005, Emerging infectious diseases.

[9]  A. Mykletun,et al.  The Association Between Anxiety, Depression, and Somatic Symptoms in a Large Population: The HUNT-II Study , 2004, Psychosomatic medicine.

[10]  S. Galea,et al.  SARS Control and Psychological Effects of Quarantine, Toronto, Canada , 2004, Emerging infectious diseases.

[11]  R. Spitzer,et al.  The PHQ-15: Validity of a New Measure for Evaluating the Severity of Somatic Symptoms , 2002, Psychosomatic medicine.